D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Armstrong World Industries
AWI
$6.86B
| $276K | ﹤0.01% |
3,061
-50,739
| -94% | -$4.31M |
|
3602
Civista Bancshares
CIVB
$594M
| $276K | ﹤0.01% |
12,029
+958
| +9% | +$19.2K |
|
3603
American States Water
AWR
$3.39B
| $275K | ﹤0.01% |
3,635
-18,599
| -84% | -$1.43M |
|
|
IPOD
3604
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $274K | ﹤0.01% |
25,000
-134,319
| -84% | -$1.91M |
|
|
ENNVU
3605
DELISTED
ECP Environmental Growth Opportunities Corp. Unit
ENNVU
| $274K | ﹤0.01% |
+27,310
| New | +$286K |
|
|
CIT
3606
DELISTED
CIT Group Inc.
CIT
| $274K | ﹤0.01% |
+5,325
| New | +$239K |
|
3607
CALL
Lear
LEA
$7.19B
| $272K | ﹤0.01% |
1,500
-24,500
| -94% | -$4.13M |
|
3608
Minerva Neurosciences
NERV
$188M
| $272K | ﹤0.01% |
11,643
-958
| -8% | -$23.9K |
|
3609
Orion
OEC
$394M
| $270K | ﹤0.01% |
13,673
-30,463
| -69% | -$549K |
|
3610
Qfin Holdings
QFIN
$1.61B
| $269K | ﹤0.01% |
+10,345
| New | +$230K |
|
3611
Timken Company
TKR
$9.82B
| $268K | ﹤0.01% |
3,307
-16,052
| -83% | -$1.28M |
|
|
LMACU
3612
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
| $268K | ﹤0.01% |
+25,000
| New | +$305K |
|
3613
Equity Bancshares
EQBK
$1.03B
| $267K | ﹤0.01% |
+9,749
| New | +$248K |
|
3614
ITT
ITT
$17.5B
| $267K | ﹤0.01% |
2,941
-19,276
| -87% | -$1.59M |
|
3615
Everspin Technologies
MRAM
$354M
| $267K | ﹤0.01% |
44,469
-58,668
| -57% | -$345K |
|
|
WPF.WS
3616
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
| $267K | ﹤0.01% |
166,666
-129,186
| -44% | -$286K |
|
|
MRNS
3617
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $266K | ﹤0.01% |
+17,203
| New | +$249K |
|
|
ITOS
3618
DELISTED
iTeos Therapeutics
ITOS
| $265K | ﹤0.01% |
7,742
+1,759
| +29% | +$63.6K |
|
3619
OneSpan
OSPN
$562M
| $265K | ﹤0.01% |
10,835
-20,286
| -65% | -$498K |
|
3620
CNO Financial Group
CNO
$4.97B
| $264K | ﹤0.01% |
+10,860
| New | +$258K |
|
|
3621
Lear
LEA
$7.19B
| $263K | ﹤0.01% |
+1,452
| New | +$245K |
|
3622
National Presto Industries
NPK
$891M
| $262K | ﹤0.01% |
2,565
-5,475
| -68% | -$539K |
|
3623
RLX Technology
RLX
$2.48B
| $262K | ﹤0.01% |
+25,331
| New | +$487K |
|
3624
CALL
Weibo
WB
$1.9B
| $262K | ﹤0.01% |
+5,200
| New | +$262K |
|
|
ZYXI
3625
DELISTED
Zynex
ZYXI
| $262K | ﹤0.01% |
18,906
+536
| +3% | +$8.18K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.